San Francisco-based therapeutics company Tenaya Therapeutics has secured $92 million in Series B funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced on Oct. 3 and led by Casdin Capital.
According to its Crunchbase profile, "Tenaya Therapeutics is a biopharmaceutical company dedicated to discovering and developing therapies for heart failure. Tenaya was founded by world-class scientists from the Gladstone Institutes' Cardiovascular Division and UT Southwestern and is backed by The Column Group. Tenaya is building a research-driven organization that targets the fundamental cellular pathologies present in diseased cardiac muscle by leveraging cutting-edge science in cardiac regeneration, induced pluripotent stem cells, and CRISPR technologies."
The three-year-old startup also raised a $50 million Series A round in 2016.
The round brings total funding raised by San Francisco companies in health care over the past month to $399 million, an increase of $187 million from the month before. The local health care industry has produced 213 funding rounds over the past year, yielding a total of $4.9 billion in venture funding.
In other local funding news, billing company Recurly announced a $19 million Series C funding round on Sept. 27, led by F-Prime Capital.
According to Crunchbase, "Recurly gracefully handles all the complexities of subscription billing and revenue optimization. Recurly Inc. provides enterprise-class recurring billing management for thousands of subscription-based SaaS, Web 2.0, Mobile, content and publishing businesses worldwide."
Founded in 2009, the company has raised three previous rounds, including a $12 million Series B round in 2014.
Also of note, software engineering and business development company Terminal raised $17 million in Series B funding, announced on Sept. 26 and led by 8VC.
From Crunchbase: "Terminal builds elite engineering teams to accelerate world-changing companies. We identify emerging tech hubs around the globe and connect the top engineers with the most compelling companies. We provide complete operations and services to give companies all the benefits of a new office without any of the hassles."
The company previously raised $10 million in Series A funding in 2018.
Rounding out the city's recent top local funding events, leisure and tourism company Aero raised $16 million in Series A funding, announced on Oct. 1.
From Crunchbase: "Aero is an air travel company that matches air travelers with premium seats or shared charters. Aero provides ticket resale for flights as an agent of registered air carriers."
The company previously raised $3.5 million in seed funding in 2018.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
